Calcifediol (monohydrate)

CAT:
804-HY-32351A-01
Size:
5 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Calcifediol (monohydrate) - image 1

Calcifediol (monohydrate)

  • UNSPSC Description:

    Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate), is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels[1][2][3].
  • Target Antigen:

    Endogenous Metabolite; VD/VDR
  • Type:

    Reference compound
  • Related Pathways:

    Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Metabolic Disease
  • Purity:

    99.89
  • Solubility:

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles:

    C=C(CC1)/C(C[C@H]1O)=C\C=C2[C@@]3([H])[C@@](CCC\2)(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC3.O
  • Molecular Weight:

    418.65
  • References & Citations:

    [1]Castoldi A, et al. Calcifediol-loaded liposomes for local treatment of pulmonary bacterial infections. Eur J Pharm Biopharm. 2016 Nov 22.|[2]Wei Zheng, et al. Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling. Biosci Rep. 2018 Dec 7;38(6):BSR20180595.Sci Rep. 2022 Feb 22;12(1):3014.|Front Pharmacol. 2020 Mar 31;11:200.|Int Immunopharmacol. 2023 Jun 30;122:110558.|Int J Mol Sci. 2017 Dec 19;18(12). pii: E2764.|Nat Chem Biol. 2022 Aug 18.|Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2117004119.|Ther Adv Endocrinol. 2020 Oct 20. |Virol Sin. 2024 Aug 19:S1995-820X(24)00134-2.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C (Powder, protect from light, stored under nitrogen)
  • Clinical Information:

    Launched
  • CAS Number:

    63283-36-3